Industries > Pharma > Clinical Trial Supply and Logistics Market for Pharma 2019-2029

Clinical Trial Supply and Logistics Market for Pharma 2019-2029

Clinical Trial Manufacturing, Clinical Trial Logistics and Distributions, Clinical Trial Supply Chain Management, Clinical Trial Packaging, Clinical Trial Cold Chain Logistics

PUBLISHED: 18 April 2019
PAGES: 204
PRODUCT CODE: PHA0415

Clear
WOOCS 2.2.1
DOWNLOAD SAMPLE

The global clinical trial supply and logistics market for pharma is estimated to have reach $17.1bn in 2018, dominated by the clinical trial manufacturing segment. The global clinical trial supply and logistics market for pharma is expected to grow at a CAGR of 7.7% in the first half of the forecast period.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 204-page report you will receive 123 charts– all unavailable elsewhere.

The 204-page report provides clear detailed insight into the global clinical trial supply and logistics market for pharma. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

• Revenue and growth forecasts from 2019 to 2029 for the global clinical trial supply and logistics market. This report also discusses the Drivers and Restraints of the global clinical trial supply and logistics market.

• Revenue and growth forecasts from 2019 to 2029 for the leading submarkets of the global clinical trial supply and logistics market:
Manufacturing – also with sub forecasting for packaging and for other production
Logistics and distribution – also with sub forecasts for cold chain logistics and for other services
Supply chain management

This report discusses the Drivers and Restraints of each submarket.

• Revenue and growth forecasts from 2019 to 2029 for the leading national markets:
• United States
• Japan
• EU5: Germany, France, United Kingdom, Italy, Spain
• Brazil
• Russia
• China
• India
• Rest of the World

Clinical Trial Supply and Logistics Market for Pharma 2019-2029

Revenues forecast for the US, Japan, EU5, Brazil, Russia, China, India are further broken down by submarket.

• This report profiles the leading companies offering clinical trial supply and logistics services to the pharmaceutical industry:
• ADAllen Pharma
• Almac Group
• Amatsigroup
• Biocair International Limited
• Catalent
• DHL
• Durbin PLC
• FedEx
• Fisher Clinical Services
• Marken
• Movianto
• Packaging Coordinators Inc.
• Parexel International
• Patheon
• Sharp Packaging Services, LLC
• TNT Express
• World Courier

• This report provides qualitative analysis of the clinical trial supply and logistics market. This report discusses the Strengths, Weaknesses, Opportunities and Threats of the clinical trial supply and logistics market. Social, Technological, Economic and Political factors that influence this market are also discussed.

• This report discusses trends in the clinical trial supply and logistics market, clinical trial manufacturing market, comparator sourcing, clinical trial packaging, clinical trial supply chain management.

• This report discusses the regulatory outlook of the clinical trial supply and logistics industry, outlook for cold chain logistics in the clinical trial sector, as well as regulatory aspects of cold chain distribution for clinical trial materials

Key Questions Answered by this Report:
• How is the clinical trial supply and logistics market for pharma evolving?
• What are the drivers and restraints for the growth of the clinical trial supply and logistics market for pharma?
• How will each clinical trial supply and logistics submarket for pharma grow over the forecast period and how much revenue will these submarkets account for in 2029?
• How will the market shares for each clinical trial supply and logistics submarket for pharma develop to 2029?
• What is the value of the leading clinical trial supply and logistics submarket for pharma s in important regions of the world?
• What will be the main driver for the overall market to 2029?
• How will the market shares of the national markets change by 2029 and which geographical region will lead the market by 2029?
• Who are the leading players and what are their prospects over the forecast period?

Visiongain’s study is intended for anyone requiring commercial analyses for the global clinical trial supply and logistics market for pharma. You find data, trends and predictions.

Buy our report today Clinical Trial Supply and Logistics Market for Pharma 2019-2029: Clinical Trial Manufacturing, Clinical Trial Logistics and Distributions, Clinical Trial Supply Chain Management, Clinical Trial Packaging, Clinical Trial Cold Chain Logistics.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Clinical Trial Supply and Logistics Market for Pharma 2019-2029


Download sample pages

Complete the form below to download your free sample pages for Clinical Trial Supply and Logistics Market for Pharma 2019-2029


Latest Pharma news

“The worldwide industry for silicone additives is likely to experience important development”, says Visiongain

It is anticipated that the benefits of silicone additives such as elevated drop, marine strength, and leveling & humidity regulate will boost their use in cosmetics, coatings, and paint applications.

16 October 2019

READ

“Global nephrology and urology devices market is anticipated to surpass USD 39 Bn by 2030”, says Visiongain

Nephrology is a field of medicine that is concerned with studying kidney function, treating kidney issues, and therapy for renal substitute.

16 October 2019

READ

“The global Nasal Drug Delivery Technology market is anticipated to surpass USD 80 Billion by 2030”, says Visiongain

Asia Pacific region is anticipated to experience the highest growth in terms of CAGR over the forecast period owing to the availability of effective treatment methods, high unmet clinical needs, rising disposable income levels, and increasing awareness about these products.

16 October 2019

READ

“The global Myeloproliferative Disorders Drugs market is anticipated to surpass USD 11 Bn by 2030”, says Visiongain

The emergence of a new therapy for myeloproliferative disorders and the accessibility of new drugs is anticipated to drive the market drugs for myeloproliferative disorders.

16 October 2019

READ

Categories

Category